Global Anti-Snoring Devices and Snoring Surgery Research Report 2023: Market to Reach $2.3 Billion by 2030 - While US Leads the Market, Asia Pacific Grows the Fastest
08 févr. 2023 08h53 HE
|
Research and Markets
Dublin, Feb. 08, 2023 (GLOBE NEWSWIRE) -- The "Anti-Snoring Devices and Snoring Surgery - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Global...
BioSig Appoints Former Qorvo CFO as Successor to Steve Chaussy
07 févr. 2023 08h00 HE
|
BioSig Technologies, Inc.
Westport, CT, Feb. 07, 2023 (GLOBE NEWSWIRE) -- Chief Financial Officer Steve Chaussy retires following 12 years of serviceSteve Buhaly joins BioSig as CFOBuhaly brings 15 years of public company...
BioSig Issues Shareholder Update to Highlight Recent Achievements and Ongoing Developments
19 janv. 2023 08h30 HE
|
BioSig Technologies, Inc.
Westport, CT, Jan. 19, 2023 (GLOBE NEWSWIRE) -- To date, the Company's FDA 510(k)-cleared PURE EP™ System has been used in approximately 3,000 patient cases across the United States The...
BioSig Executes Agreement with Bellin Health for the Acquisition of its PURE EP™ Technology
10 janv. 2023 08h30 HE
|
BioSig Technologies, Inc.
Westport, CT, Jan. 10, 2023 (GLOBE NEWSWIRE) -- Leading Midwest healthcare system reports significant cost savings and noise reduction following evaluation of the PURE EP™ System Medical center...
Update: BioSig’s PURE EP™ System Demonstrates Potential Time and Cost Savings at the 15th APHRS Scientific Session in Singapore
14 déc. 2022 16h30 HE
|
BioSig Technologies, Inc.
Westport, CT, Dec. 14, 2022 (GLOBE NEWSWIRE) -- - BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), an advanced digital signal processing technology company delivering...
BioSig’s PURE EP™ System Demonstrates Potential Time and Cost Savings at the 15th APHRS Scientific Session in Singapore
14 déc. 2022 08h00 HE
|
BioSig Technologies, Inc.
Westport, CT, Dec. 14, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), an advanced digital signal processing technology company delivering...
BioSig’s PURE EP™ System Highlighted in the Journal of Atrial Fibrillation & Electrophysiology
06 déc. 2022 08h30 HE
|
BioSig Technologies, Inc.
Westport, CT, Dec. 06, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”) an advanced digital signal processing technology company delivering unprecedented...
Global Endometrial Ablation Devices Market Report 2022-2028 Featuring Minerva Surgical, Hologic, Medtronic, Cooper Co, Olympus, J&J, AngioDynamics, Richard Wolf, Karl Storz, Idoman Teoranta
26 oct. 2022 08h38 HE
|
Research and Markets
Dublin, Oct. 26, 2022 (GLOBE NEWSWIRE) -- The "Global Endometrial Ablation Devices Market - Analysis By Device Type, End-User By Region, By Country (2022 Edition): Market Insights and Forecast with...
BioSig Signs Master Research Agreement with Cleveland Clinic to Explore Expanded Applications for its Digital Signal Processing Technology
24 oct. 2022 11h03 HE
|
BioSig Technologies, Inc.
Westport, CT, Oct. 24, 2022 (GLOBE NEWSWIRE) -- Medical Center of Excellence to leverage the Company’s PURE EP™ System to further its research and educational objectives as a leader in cardiac...
BioSig Invited to Attend and Sponsor Venice Arrhythmias 2022
12 oct. 2022 10h00 HE
|
BioSig Technologies, Inc.
Westport, CT, Oct. 12, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”) an advanced digital signal processing technology company delivering unprecedented...